Greetings. I'd like to do a de novo assembly using Velvet 1.2.10 from reads of two different Illumina , one with 50 basepair reads and a 115bp insert, one with 250bp reads and 550bp insert. For velveth, how what insert size do I give it? An average? Pick the larger one? Thanks!
Unconfigured Ad
Collapse
X
-
Tags: None
-
you can use both.
the 2 sets of reads will be flagged as -shortPaired and -shortPaired2, respectively, when you run velveth, and the insert lengths can be
specified using the parameters -ins_length, -ins_length_sd, -ins_length2 and
-ins_length2_sd when you run velvetg.
-
@mastal, thanks! I actually specified the 250bp reads as -longPaired. Do you think that was unwise?
Comment
-
From the velvet manual:
5.6 What’s long and what’s short?
Velvet was pretty much designed with micro-reads (e.g. Illumina) as short and
short to long reads (e.g. 454 and capillary) as long. Reference sequences can
also be thrown in as long.
That being said, there is no necessary distinction between the types of reads.
The only constraint is that a short read be shorter than 32kb. The real difference
is the amount of data Velvet keeps on each read. Short reads are presumably
too short to resolve many repeats, so only a minimal amount of information is
kept. On the contrary, long reads are tracked in detail through the graph.
This means that whatever you call your reads, you should be able to obtain
the same initial assembly. The differences will appear as you are trying to resolve
repeats, as long reads can be followed through the graph. On the other hand,
long reads cost more memory. It is therefore perfectly fine to store Sanger reads
as “short” if necessary.
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
26 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
20 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
36 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
43 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Comment